Markets & Companies

A Visible Turning Point for Oxea

07.02.2017 - Ten years ago, in March 2007, oxo chemicals producer Oxea was established as a buyout led by private-equity firm Advent International of oxo derivatives and oxo intermediates...

News

Chemtura Shareholders Approve Sale to Lanxess

02.02.2017 - Shareholders of US additives specialist Chemtura have given the green light for the company to be acquired by Germany’s Lanxess. In September of last year, the German company...

News

Trump Discusses Issues With Drugmakers

01.02.2017 - In a meeting at the White House on Jan. 31, new US president, Donald Trump, held out both a carrot and a stick to pharmaceutical producers. The industry will “have to “get prices...

News

Russia Sells Nearly 20% of Rosneft to Investors

31.01.2017 - More than a month after Russia announced one of its biggest privatizations since the 1990s, the true identity of the buyers of a 19.5% stake in its national oil company Rosneft has...

News

J&J Clinches Actelion for $30 Billion

27.01.2017 - Johnson & Johnson (J&J) has won its battle to acquire Swiss biotechnology firm Actelion. The deal announced on Jan. 26 foresees the New Jersey, USA-based healthcare company...

News

EU Chemical Business Gains Momentum

27.01.2017 - Chemical business in the European Union became more favorable in the fourth quarter of 2016, compared to the rest of the year, and economic sentiment in the euro zone improved on...

News

Hydrogen Council Launched at World Economic Forum

20.01.2017 - Among the “firsts” launched at the 2017 World Economic Forum in Davos, Switzerland, were – unusually – two projects in which the global chemicals-related industry got its day in...

News

Bayer Promises Trump $8 Billion for US Research?

18.01.2017 - A second chemical-pharmaceuticals company may have won points toward US approval of its mega-merger plans by making promises of research spending and job creation to President...

News

Pharma Stocks Crash on Trump Pricing Hints

13.01.2017 - American drugmakers, who had hoped US President-Elect Donald Trump would go easier on the industry than Hillary Clinton and Bernie Sanders had promised to do, received an...

News

Value of Pharma M&A Doubled in 2016

06.01.2017 - Pharmaceutical companies paid twice as much for acquisitions in 2016 than a year earlier, according to an analysis of the 316 drugs-sector deals of the past three years carried out...